Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Oral Human Insulin Enteric Coated Capsules in Healthy Chinese Males
NCT06519604Phase 1Active, not recruiting
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jul 2024
- Primary completion
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of human insulin in diabetes mellitus (DM) (3 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoints: Maximum Glucose Infusion Rate, Time to Maximum Glucose Infusion Rate and 1 more. Started Jul 2024; status: active, not recruiting.
02
Drugs
human insulin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT06519604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06519604.